Neuroscience
Parkinson's Disease
100%
Alpha-Synuclein
78%
Sumoylation
45%
Dopaminergic
39%
Neurodegenerative Disorder
27%
Oxidative Stress
22%
Glutathione
21%
Astrocyte
18%
In Vivo
16%
In Vitro
16%
Synuclein
16%
Neuroprotective Agent
16%
Neurodegeneration
12%
NADPH Oxidase
10%
Cellular Senescence
10%
Transcranial Magnetic Stimulation
10%
Parkin
10%
Dopamine Uptake
10%
Glutamate Carboxypeptidase
10%
Dopamine Transporter
10%
Cell Death
10%
Olfactory Bulb
10%
Protein Aggregation
10%
Dopaminergic Neuron
7%
Microglia
7%
Stereotypic Movement Disorder
7%
Bipolar Disorder
6%
Doxycycline
6%
Striatum
5%
Mouse Brain
5%
GSK-3
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
97%
Carbidopa
21%
Dyskinesia
21%
Calpain 1
21%
Levodopa
21%
Mouse Model
21%
Dopamine Receptor Stimulating Agent
13%
Alpha Synuclein
13%
Oxidoreductase Inhibitor
10%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
10%
Myocarditis
10%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
10%
Mitochondrial Permeability Transition Pore
10%
Combination Therapy
10%
Fructose Bisphosphate Aldolase
10%
Experimental Autoimmune Myocarditis
10%
Cell Viability
6%
Calpain
6%
Triacylglycerol
5%
Lipopolysaccharide
5%
Medicine and Dentistry
Parkinson's Disease
54%
Alpha Synuclein
34%
Sumoylation
32%
Oxidative Stress
15%
In Vitro
13%
Degenerative Disease
12%
Synuclein
10%
Infectious Disease
10%
Staphylococcus aureus
10%
Astrocyte
10%
Transcranial Magnetic Stimulation
10%
Fibril
10%
Cell Death
10%
Oxidoreductase Inhibitor
10%
Escherichia coli
10%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
10%
Reactive Oxygen Species
9%
Protein Aggregation
6%
Pandemic
5%
Bactericidal Activity
5%
Pathogen
5%
Electromagnetic Field
5%
Bacterial Growth
5%
Salmonella Enterica Subsp. Enterica
5%
